Search research articles
Contact Us
Filters
Showing results (31-40 of 171) with videos related to
Page
of 18
Sort By:
Translational Lung Cancer Research
|
January 11, 2024
An advanced NSCLC patient with <i>ALK-RNF144A</i> and <i>HIP1-ALK</i> fusions treated with <i>ALK</i>-TKI combination therapy: a case report
Hui Li, Jingjing Liu, Shaowei Lan, et al.
Cancers
|
April 30, 2021
Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis
Florian Eichhorn, Mark Kriegsmann, Laura V Klotz, et al.
Case Reports in Surgery
|
December 11, 2012
Retroperitoneal Abscess Formation as a Result of Spilled Gallstones during Laparoscopic Cholecystectomy: An Unusual Case Report
Grigoris Chatzimavroudis, Stefanos Atmatzidis, Basilis Papaziogas, et al.
Oncoimmunology
|
December 8, 2018
Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden
Jan Budczies, Anja Seidel, Petros Christopoulos, et al.
Cancer & Metabolism
|
June 16, 2025
Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis
Ann-Kathrin Daum, Lisa Schlicker, Marc A Schneider, et al.
Expert Review of Anticancer Therapy
|
February 5, 2026
The role of zongertinib, a highly selective tyrosine kinase inhibitor, in targeting <i>HER2</i>-mutant NSCLC: a bench-to-bedside review
John V Heymach, Sanjay Popat, Egbert F Smit, et al.
BMC Cancer
|
August 27, 2020
Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, et al.
Translational Lung Cancer Research
|
June 19, 2025
Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis
Liang Liu, Wen Bao, Xiaoshuai Yuan, et al.
Cancers
|
April 30, 2021
Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for Redefinition
Philip Baum, Samantha Taber, Stella Erdmann, et al.
The American Journal of Surgical Pathology
|
April 26, 2021
Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung
Abbas Agaimy, Robert Stoehr, Michael Michal, et al.
Page
of 18
Search research articles
Search
Showing results (31-40 of 171) with videos related to
Sort By:
Page
of 18
Translational Lung Cancer Research
|
January 11, 2024
An advanced NSCLC patient with <i>ALK-RNF144A</i> and <i>HIP1-ALK</i> fusions treated with <i>ALK</i>-TKI combination therapy: a case report
Hui Li, Jingjing Liu, Shaowei Lan, et al.
Cancers
|
April 30, 2021
Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis
Florian Eichhorn, Mark Kriegsmann, Laura V Klotz, et al.
Case Reports in Surgery
|
December 11, 2012
Retroperitoneal Abscess Formation as a Result of Spilled Gallstones during Laparoscopic Cholecystectomy: An Unusual Case Report
Grigoris Chatzimavroudis, Stefanos Atmatzidis, Basilis Papaziogas, et al.
Oncoimmunology
|
December 8, 2018
Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden
Jan Budczies, Anja Seidel, Petros Christopoulos, et al.
Cancer & Metabolism
|
June 16, 2025
Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis
Ann-Kathrin Daum, Lisa Schlicker, Marc A Schneider, et al.
Expert Review of Anticancer Therapy
|
February 5, 2026
The role of zongertinib, a highly selective tyrosine kinase inhibitor, in targeting <i>HER2</i>-mutant NSCLC: a bench-to-bedside review
John V Heymach, Sanjay Popat, Egbert F Smit, et al.
BMC Cancer
|
August 27, 2020
Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, et al.
Translational Lung Cancer Research
|
June 19, 2025
Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis
Liang Liu, Wen Bao, Xiaoshuai Yuan, et al.
Cancers
|
April 30, 2021
Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for Redefinition
Philip Baum, Samantha Taber, Stella Erdmann, et al.
The American Journal of Surgical Pathology
|
April 26, 2021
Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung
Abbas Agaimy, Robert Stoehr, Michael Michal, et al.
Page
of 18